This article is intended for primary care clinicians, otolaryngologists, infectious disease specialists, and other specialists who provide care to adults and children with chronic otitis media.
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.
Upon completion of this activity, participants will be able to:
As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should only claim credit commensurate with the extent of their participation in the activity. Medscape Medical News has been reviewed and is acceptable for up to 300 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 09/01/07. Term of approval is for 1 year from this date. This activity is approved for 0.25 Prescribed credits. Credit may be claimed for 1 year from the date of this activity. AAFP credit is subject to change based on topic selection throughout the accreditation year.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 5 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CME Released: 3/19/2008
Valid for credit through: 3/19/2009
processing....
March 19, 2008 — Patients with chronic otitis media (COM) in 1 ear are highly likely to have structural or other abnormalities in the contralateral ear, according to the results of a study reported in the March issue of the Archives of Otolaryngology—Head & Neck Surgery.
"According to the continuum theory, OM with effusion (OME) is recognized as the initial condition that, when unresolved, may progress to chronic transformation," write Sady Selaimen da Costa, MD, PhD, from the Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, and colleagues. "Although only a small percentage of the ears with OME will evolve to have COM, our question is this: Considering that the presence of bilateral effusion is reported to be high, should not the prevalence of bilateral COM be similarly prevalent?. . . . The current study reports the characteristics of the contralateral ear (CLE) in a series of patients with COM with the specific objectives of (1) studying the existence of pathologic changes in the CLE of patients with COM and (2) comparing findings in patients with COM with cholesteatoma vs those without."
At a tertiary referral center, 500 consecutive patients diagnosed with COM with or without cholesteatoma underwent digital otoendoscopy on both ears. The primary endpoint was pathologic alterations in the CLE.
Structural abnormalities were found in the CLE in 75.2% of the patients. COM without cholesteatoma was present in 60.4% of the patients, and in this group, 69.9% had abnormal findings in the CLE. In patients with cholesteatoma, 83.3% had abnormal findings in the CLE. Retraction of the tympanic membrane was the most common finding in both groups.
"Patients with COM in 1 ear have a high chance of presenting with some degree of disease in the contralateral side," the study authors write. "We believe that our findings suggest that COM should be ideally approached not as a static pathological incident affecting 1 ear but rather as an ongoing process that may affect both ears.... The CLE should always be comprehensively studied in patients with unilateral COM to efficiently diagnose the alterations and, if necessary, provide timely therapeutic intervention."
The study authors have disclosed no relevant financial relationships.
Arch Otolaryngol Head Neck Surg. 2008;134:290-293.
Otitis media with effusion can progress to COM. The authors of the current study propose that because otitis media with effusion is often bilateral, COM might also be found in both ears.
In the April 1984 issue of the Journal of Laryngology and Otology, Chalton and Stearns noted that 53.4% of patients with cholesteatoma had abnormalities in the CLE. In the March 1996 issue of the American Journal of Otology, Vartiainen and colleagues reported that 63% of patients with COM with or without cholesteatoma had abnormalities of the tympanic membrane in the CLE.
This study evaluates the prevalence of pathologic findings in the contralateral tympanic membrane in patients with COM overall with or without cholesteatoma and describes the pathologic findings in the contralateral tympanic membrane.